The Patent Finder

Vela Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Vela Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Vela Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 6,683,072Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
Term ended
Term ended Feb 4, 2023 · From the USPTO record
Term endedTerm ended Feb 4, 2023From the USPTO record
US 6,649,607Compositions and methods for treating or preventing convulsions or seizures
Formerly held
Term ended
Term ended Nov 9, 2021 · From the USPTO record
Term endedTerm ended Nov 9, 2021From the USPTO record
US 7,541,355Conversion process for 2,3-benzodiazepine enantiomers
Lapsed on the fee record
Ended Jun 2, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 2, 2021From the USPTO record
US 6,358,944Methods and compositions for treating generalized anxiety disorder
Term ended
Term ended Aug 23, 2020 · From the USPTO record
Term endedTerm ended Aug 23, 2020From the USPTO record
US 6,395,788Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine
Formerly held
Term ended
Term ended Aug 11, 2020 · From the USPTO record
Term endedTerm ended Aug 11, 2020From the USPTO record
US 6,541,523Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine
Formerly held
Term ended
Term ended Aug 11, 2020 · From the USPTO record
Term endedTerm ended Aug 11, 2020From the USPTO record
US 6,080,736Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam
Formerly held
Term ended
Term ended Oct 27, 2019 · From the USPTO record
Term endedTerm ended Oct 27, 2019From the USPTO record
US 7,078,398Compositions and methods for treating or preventing convulsions or seizures
Lapsed on the fee record
Ended Jul 18, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jul 18, 2018From the USPTO record
US 7,265,106Method for isolating (R)-tofisopam
Lapsed on the fee record
Ended Sep 4, 2015 · From the USPTO record
Lapsed on the fee recordEnded Sep 4, 2015From the USPTO record
US 7,745,431Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5H-2,3-benzodiazepine and uses thereof
Lapsed on the fee record
Ended Jun 29, 2014 · From the USPTO record
Lapsed on the fee recordEnded Jun 29, 2014From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited